PEPTIDE Registry

Reported experiences and published evidence, kept separate. Explore what people seek, what sources actually study and what remains unknown.

Collection closed. No participant results published.

What would you like to explore?

All groups and topics

Reported-use topics, not evidence grades or diagnoses. The catalog does not cover every possible experience.

Dihexa

Editorial context from existing sources; independent scientific review pending. Numerical findings held. A reported-use topic does not establish direct evidence for that aim.

Dihexa is an experimental peptidomimetic studied in laboratory and animal models. A key 2014 HGF/c-Met mechanism paper was retracted in 2025; the separate 2013 discovery study carries a 2021 notice of concern. Other animal studies report model-dependent findings, including benefits in some memory tasks and a negative result in a rat model of Huntington-like disease. Additional preclinical work supports investigation of HGF/MET involvement, but the sources reviewed do not establish cognitive benefit, safety, or a validated dosing regimen in people. Laboratory potency comparisons must not be presented as proof of clinical superiority over BDNF. Scientific/expert review pending.

Claims that relied on that paper need independent confirmation. The retraction does not establish that every possible claim about Dihexa is false, and it does not supply human efficacy or safety evidence either.

Sources and proposed-mechanism explanation

The proposed mechanism attracted interest, but a plausible pathway depends on reliable supporting experiments.

Collection, review and methods

8 documents · 24 educational profiles · 10 guides. Hosting authorization and reviews remain pending. Drafts are not reports; they do not establish effectiveness or safety.

Methods, consent and privacy
A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.